SOURCE: Oncology Med

November 26, 2007 09:00 ET

Oncology Med Signs Multi-Year Contract With Meadville Medical Center's New Comprehensive Cancer Treatment Facility

Contract Revenues Expected to Approximate $300,000.00

PITTSBURGH, PA--(Marketwire - November 26, 2007) - Oncology Med, Inc. (PINKSHEETS: ONCO), a Pittsburgh-based cancer treatment solutions group, announced today that it has signed a new multi-year exclusive contract with the Meadville Medical Center in Meadville, Pennsylvania providing Meadville's state-of-the-art, full-service cancer treatment center with a full range of medical physics support to include radiation shielding design and analysis, equipment acceptance and commissioning and on-going medical physics consulting services. Oncology Med was selected by Meadville over several competitors.

According to William Walker, Ph.D., Oncology Med's CEO and founder, "We are excited to have been made a part of this innovative project. The center will include the latest and best available treatment modalities in a unique patient friendly environment. While many major hospital systems do have their own internal cancer programs and physics departments and staff, Oncology Med is seeing a substantial increase in the number of hospitals contracting those programs and services, either in whole or in part, to outside agencies such as ours to meet the growing demands of staff and technology as radiation treatment expands to be the key treatment of choice for most cancer patients," Walker contended.

Oncology Med's Vice President of Business Development Jack Sloan added, "We are on schedule to significantly increase our revenues through new contracts both in the traditional medical physics arena and with our new Brachytherapy initiatives. This new contract demonstrates our continued dominance in our market and is another of the many new contracts that we hope to announce to our investors and other interested parties over the next several quarters. We also anticipate at least two or three additional new major contracts in the first quarter of the new year as we are aggressively pursuing new clients and contracted sites."

"We consider our company to be unique in the market in comparison to other turnkey cancer service providers who are only capable of offering one or two basic services. Oncology Med can enter the competitive arena of turnkey cancer solutions with all services under one roof, provide faster installation of new programs, equipment, services, and staff, and do so at a lower cost to the client than our competitors. Oncology Med is a full-service clinical company to which many management companies have turned in the past to fulfill their obligations in providing turnkey cancer solutions."

In addition to physics staffing and support, Oncology Med continues to expand and provide extensive consultation services for new and expanded cancer center construction, certification, and credentialing processes for Joint Commission, as well as, complete turnkey programs for continuation or implementation of radiation treatment programs for ambulatory surgery centers, radiation oncologists, urologists, and hospitals.

About Oncology Med, Inc.

Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation treatments to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.

More information about Oncology Med, Inc. can be found at

NOTE: This press release may contain "forward-looking statements." In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results.

Contact Information

  • For information, please contact:
    Mr. Trevor Bentley
    Investor Communications
    Bentley Communications
    Email Contact